Unsere Publikationen

Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management

Link
https://doi.org/10.1177/1352458518816612
Tags
Multiple SkleroseMS Behandlung
Jahr
2020
Autoren
Cuker A, Bass AD, Nadj C, Agius MA, Steingo B, Selmaj KW, Thoits T, Guerreiro A, Van Wijmeersch B, Ziemssen T, Meuth SG, LaGanke CC, Thangavelu K, Rodriguez CE, Baker DP, Margolin DH, Jannsens A.
Verlag
Mult Scler. 2020 Jan;26(1):48-56.
Zum Eintrag

How to implement adherence-promoting programs in clinical practice? A discrete choice experiment on physicians’ preferences

Link
https://doi.org/10.2147/ppa.s222725
Tags
Multiple Sklerose
Jahr
2020
Autoren
Müller S, Ziemssen T, Diehm C, Duncker T, Hoffmanns P, Thate-Waschke IM, Schürks M, Wilke T.
Verlag
Patient Prefer Adherence. 2020 Feb 14;14:267-276.
Zum Eintrag

Health-related quality of life and the relationship to treatment satisfaction in patients with multiple sclerosis: Insights from a large observational study

Link
https://doi.org/10.2147/ppa.s248272
Tags
Multiple SkleroseManagement & Science
Jahr
2020
Autoren
Schriefer D, Haase R, Kullmann JS, Ziemssen T.
Verlag
Patient Preference Adherence 2020;14:869-880.
Zum Eintrag

Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients

Link
https://doi.org/10.1177/1756286420960274
Tags
Multiple SkleroseManagement & ScienceGesundheitsökonomie
Jahr
2020
Autoren
Schriefer D, Ness N-H, Haase R, Ziemssen T.
Verlag
Ther Adv Neurol Disord 2020;13.
Zum Eintrag

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

Link
https://doi.org/10.1177/2055217320972137
Tags
Multiple SkleroseMS Behandlung
Jahr
2020
Autoren
Horáková D, Boster A, Bertolotto A, Freedman MS, Firmino I, Cavalier SJ, Jacobs AK, Thangavelu K, Daizadeh N, Poole EM, Baker DP, Margolin DH, Ziemssen T; CARE-MS I, CARE-MS II, and CAMMS03409 Investigators.
Verlag
Mult Scler J Exp Transl Clin. 2020 Dec 18;6(4):2055217320972137.
Zum Eintrag

On the reliability of examining dual-tasking abilities using a novel e-health device – a proof of concept study in multiple sclerosis

Link
https://doi.org/10.3390/jcm9113423
Tags
Management & ScienceeHealth
Jahr
2020
Autoren
Böttrich N, Mückschel M, Dillenseger A, Lange C, Kern R, Ziemssen T, Beste C.
Verlag
J Clin Med. 2020 Oct 25;9(11):3423.
Zum Eintrag

Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis

Link
https://doi.org/10.3389/fimmu.2020.00056
Tags
Multiple SkleroseMS BehandlungNeuroimmunologie
Jahr
2020
Autoren
Akgün K, Blankenburg J, Marggraf M, Haase R, Ziemssen T.
Verlag
Front Immunol 2020;11.
Zum Eintrag

Pneumocystis pneumonia in a patient treated with alemtuzumab for relapsing multiple sclerosis

Link
https://doi.org/10.1016/j.msard.2019.101503
Tags
Multiple SkleroseMS Behandlung
Jahr
2020
Autoren
Lau AY, Lui GCY, Chan K-, Au C, Mok VCT, Ziemssen T.
Verlag
Mult Scler Relat Disord 2020;38.
Zum Eintrag

Publikationen durchsuchen

Publikationen filtern

Filters
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Show AllHide
Jahr
-